Portopulmonary hypertension in decompensated cirrhosis with refractory ascites
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background: The prevalence of portopulmonary hypertension (PPHTN) in patients with cirrhosis and refractory ascites is unknown. Its presence may preclude patients from receiving a transjugular intrahepatic portosystemic shunt or liver transplantation as a definitive treatment for their end stage cirrhosis. Purpose: To determine the prevalence, possible aetiological factors, and predictive factors for the development of PPHTN in these patients. Methods: Sixty two patients (53 males, nine females; mean age 54.5 (1.4) years) with biopsy proven cirrhosis and refractory ascites underwent angiographic measurements of pulmonary and splanchnic haemodynamics. Endothelin 1 levels were measured from the pulmonary artery. Forty nine patients underwent radionuclide angiography for measurements of central blood volume, pulmonary vascular, and cardiac chamber volumes. Forty seven patients also underwent two dimensional echocardiography for measurements of cardiac structural and functional parameters. Cardiac output, and systemic and pulmonary vascular resistance were calculated. Results: Ten patients (16.1%) fulfilled the criteria for PPHTN (mean pulmonary artery pressure ≥25 mm Hg and pulmonary vascular resistance ≥120 dyn×s/cm 5 ), with significantly higher mean right atrial (15.4 (1.2) v 7.9 (0.5) mm Hg; p<0.001), and right ventricular pressures (24.7 (1.5) v 14.7 (0.6) mm Hg; p<0.001), and endothelin 1 levels (3.04 (0.40) v 1.98 (0.12) pg/ml; p=0.02). No significant differences in any of the other parameters measured were detected between the two groups. A right atrial pressure of ≥14 mm Hg had a 83% positive predictive value for the presence of PPHTN. Conclusions: Portopulmonary hypertension is common in cirrhosis with refractory ascites, possibly due to excess endothelin 1 in the pulmonary circulation. An elevated right atrial pressure ≥14 mm Hg predicts the presence of PPHTN, which may be helpful in deciding management options in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
Arroyo, V, Ginès, P., Gerbes, A. L., Dudley, F. J., Gentilini, P., Laffi, G., Reynolds, T. B., Ring-Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,703
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
Stewart, D. J., Levy, R. D., Cernacek, P., & Langleben, D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-6-464 · Cited by 980
Krowka, M. J., Plevak, D. J., Findlay, J. Y., Rosen, C. B., Wiesner, R. H., & Krom, R. A. F. (2000) · Liver Transplantation · doi:10.1053/jlts.2000.6356 · Cited by 611
Hadengue, A., Benhayoun, M. K., Lebrec, D., & Benhamou, J.-P. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90225-a · Cited by 499
Pinzani, M., Milani, S., De Franco, R., Grappone, C., Caligiuri, A., Gentilini, A., Tosti- Guerra, C., Maggi, M., Failli, P., Ruocco, C., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566602 · Cited by 404
Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease
Scott, E. M., Gaywood, I., & Scott, B. B. (2000) · Gut · doi:10.1136/gut.46.suppl_1.i1 · Cited by 377
Pulmonary vascular disorders in portal hypertension
Herve, P., Lebrec, D., Brenot, F., Simonneau, G., Humbert, M., Sitbon, O., & Duroux, P. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11051153 · Cited by 360
Cirrhotic Cardiomyopathy: Getting to the Heart of the Matter
Ma, Z., & Lee, S. S. (1996) · Hepatology · doi:10.1002/hep.510240226 · Cited by 345
Dwyer, J. H., Navab, M., Dwyer, K. M., Hassan, K., Sun, P., Shircore, A., Hama-Levy, S., Hough, G., Wang, X., Drake, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.24.2922 · Cited by 337
Primary Pulmonary Hypertension and Cirrhosis: Are They Related? 1– 3
McDonnell, P. J., Toye, P. A., & Hutchins, G. M. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.127.4.437 · Cited by 315
Human Pulmonary Circulation Is an Important Site for Both Clearance and Production of Endothelin-1
Dupuis, J., Stewart, D. J., Cernacek, P., & Gosselin, G. (1996) · Circulation · doi:10.1161/01.cir.94.7.1578 · Cited by 302
Robalino, B. D., & Moodie, D. S. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80121-4 · Cited by 296
The cardiac response to exercise in cirrhosis
Wong, F., Girgrah, N., Graba, J., Allidina, Y., Liu, P., & Blendis, L. (2001) · Gut · doi:10.1136/gut.49.2.268 · Cited by 294
Self-citationPozzi, M., Carugo, S., Boari, G., Pecci, V, de Ceglia, S., Maggiolini, S., Bolla, G. B., Roffi, L., Failla, M., Grassi, G., et al. (1997) · Hepatology · doi:10.1002/hep.510260507 · Cited by 287
Castro, M., Krowka, M. J., Schroeder, D. R., Beck, K. C., Plevak, D. J., Rettke, S. R., Cortese, D. A., & Wiesner, R. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.6.543 · Cited by 266
Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay
Sugiura, M., Inagami, T., & Kon, V. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91372-7 · Cited by 260
Barst, R. J., Rich, S., Widlitz, A., Horn, E. M., McLaughlin, V., & McFarlin, J. (2002) · Chest · doi:10.1378/chest.121.6.1860 · Cited by 241
Circulating levels of endothelin in cirrhosis
Asbert, M., Ginès, A., Ginès, P., Jiménez, W., Clària, J., Saló, J., Arroyo, V., Rivera, F., & Rodés, J. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90360-o · Cited by 199
Givertz, M. M., Colucci, W. S., LeJemtel, T. H., Gottlieb, S. S., Hare, J. M., Slawsky, M. T., Leier, C. V., Loh, E., Nicklas, J. M., & Lewis, B. E. (2000) · Circulation · doi:10.1161/01.cir.101.25.2922 · Cited by 161
Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension
Stelzner, T. J., OʼBrien, R. F., Yanagisawa, M., Sakurai, T., Sato, K., Webb, S., Zamora, M., McMurtry, I. F., & Fisher, J. (1992) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1992.262.5.l614 · Cited by 161
Nitric Oxide and Endothelin-1 in Pulmonary Hypertension
Giaid, A. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.208s · Cited by 157
Endothelin-1 in the lungs of patients with pulmonary hypertension
Cacoub, P. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00189-7 · Cited by 146
Wong, F. S.-H., Liu, P. J., Lilly, L., Bomzon, A., & Blendis, L. M. (1999) · Clinical Science · doi:10.1042/cs0970259 · Cited by 144
Self-citationHepatopulmonary syndromes: Table 1
Krowka, M. J. (2000) · Gut · doi:10.1136/gut.46.1.1 · Cited by 135
PORTOPULMONARY HYPERTENSION AND THE LIVER TRANSPLANT CANDIDATE
Kuo, P. C., Plotkin, J. S., Gaine, S., Schroeder, R. A., Rustgi, V. K., Rubin, L. J., & Johnson, L. B. (1999) · Transplantation · doi:10.1097/00007890-199904270-00001 · Cited by 135
Gerbes, A. L., Møller, S., Gülberg, V., & Henriksen, J. H. (1995) · Hepatology · doi:10.1002/hep.1840210321 · Cited by 121
α1-Adrenergic Hypothesis for Pulmonary Hypertension
Salvi, S. S. (1999) · CHEST Journal · doi:10.1378/chest.115.6.1708 · Cited by 111
Cardiopulmonary dysfunction in cirrhosis
Liu, H., & Lee, S. S. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01920.x · Cited by 107
Central blood volume in cirrhosis: Measurement with radionuclide angiography
Wong, F. S.-H., Liu, P. J., Tobe, S. W., Morali, G. A., & Blendis, L. M. (1994) · Hepatology · doi:10.1002/hep.1840190208 · Cited by 89
Self-citationMEDIATORS, CYTOKINES, AND GROWTH FACTORS IN LIVER-LUNG INTERACTIONS
Panos, R. J., & Baker, S. K. (1996) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70305-1 · Cited by 76
Nagasue, N., Dhar, D. K., Yamanoi, A., Emi, Y., Udagawa, J., Yamamoto, A., Tachibana, M., Kubota, H., Kohno, H., & Harada, T. (2000) · Hepatology · doi:10.1053/he.2000.6596 · Cited by 75
Pathophysiology of Pulmonary Hypertension
Higenbottam, T. (1994) · CHEST Journal · doi:10.1378/chest.105.2_supplement.7s · Cited by 68
Alam, I., Bass, N. M., Bacchetti, P., Gee, L., & Rockey, D. C. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00743-1 · Cited by 67
Cardiopulmonary effects of endothelin-1 in man
Kiely, D. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00219-2 · Cited by 65
Tsai, Y., Lin, H., Yang, M. C. M., Lee, F.-Y., Hou, M., CHEN, L., & Lee, S. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80034-4 · Cited by 54
Martinet, J.-P., Legault, L., Černáček, P., Roy, L. F., Dufresne, M., Spahr, L., Fenyves, D., & Pomier–Layrargues, G. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80241-8 · Cited by 40
Eakes, A. T., Howard, K. M., Miller, J. E., & Olson, M. S. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.3.g605 · Cited by 38
Gerbes, A. (1995) · Hepatology · doi:10.1016/0270-9139(95)90526-x · Cited by 15
Cited by
Portopulmonary hypertension and hepatopulmonary syndrome
Hoeper, M. M., Krowka, M. J., & Strassburg, C. P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16107-2 · Cited by 504
Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups
Swanson, K. L., Wiesner, R. H., Nyberg, S. L., Rosen, C. B., & Krowka, M. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02384.x · Cited by 339
Metadata
- Authors
- Benjaminov, F. S., Prentice, M., Sniderman, K. W., Siu, S., Liu, P., & Wong, F.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2003-08-11
- Volume
- 52
- Issue
- 9
- Pages
- 1355-1362
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2053640864
- Cited by
- 184
- References
- 42
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.